US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.
Blue Water Vaccines, a US-based influenza shot developer based on University of Oxford research, is seeking $15m in funding from undisclosed investors. Blue Water has entered an option agreement with Oxford to advance the concept of a universal influenza jab pioneered in the Department of Zoology. The vaccine will function by hitting viral modules whose…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
